MedPath

Heat Intolerance- A Lesson From Global Genomic Response in Lymphocytes

Conditions
Genotypic Variations
Genomic Markers for Predisposition of Heat Intolerance
Gene Expression
Heat Intolerance
Registration Number
NCT00918359
Lead Sponsor
Medical Corps, Israel Defense Force
Brief Summary

Heat Intolerance (HI) is a life threatening deficiency that can lead to heat exhaustion, heat stroke (and possibly death) in a large number of military and civilian occupational groups. We have demonstrated malfunction of transcriptional pathways in the heat stressed HI phenotype and an altered gene expression profile compared to Heat Tolerant (HT) individuals. Such differences are evident even under normothermic basal/comfort conditions. Heat and exercise challenges during the heat tolerance test (HTT) further emphasize the differences between the groups, particularly during recovery at comfort temperatures. Our results indicate that it may be possible to identify markers of heat intolerance. To achieve this goal, we plan to design a cellular (lymphocyte) HTT experimental model and detect gene expression profiles using customized DNA microarrays and bioinformatic tools (the genes selected will be based on our previous DNA microarray studies). Lymphocyte samples collected from HT and HI individuals under resting/comfort conditions will be examined. Treatments and analyses are designed to reveal HI-associated gene-expression profiles (constitutive or inducible), and thereby find lymphocyte markers to identify individuals predisposed to heat injury. The identification of such subjects could prevent unnecessary loss of life. Notably, the rapidly changing climate in our era increases the number of occupation/age groups in which manifestations of HI will appear.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • Experienced heat exhaustion or heat stroke in their past
  • Participating in heat tolerance tests (HTT)
Exclusion Criteria
  • Unambiguous result of the HTT
  • HTT stop by the subject decision

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Heller Institute of Medical Research

🇮🇱

Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath